Boehringer Ingelheim
Holger Klein is a skilled professional in computational biology with extensive experience in leading scientific research and strategic initiatives. Currently serving as Senior Principal Scientist at Boehringer Ingelheim, Holger advances therapeutic area strategies and methods, previously contributing to cross-therapeutic area machine learning and artificial intelligence growth. Holger has held significant roles such as Associate Director of Lead Computational Biology focusing on cardiometabolic diseases and has a notable background in bioinformatics, including heading a core facility at the Institute of Molecular Biology and establishing bioinformatics resources at MicroDiscovery GmbH. Holger's academic credentials include a Dr. rer. nat. in Bioinformatics from Free University Berlin and a Dipl. Chem. in Chemistry from the University of Cologne.
This person is not in any teams
This person is not in any offices